Compare SNN & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNN | FMS |
|---|---|---|
| Founded | 1856 | 1996 |
| Country | United Kingdom | Germany |
| Employees | 16988 | 108165 |
| Industry | Industrial Specialties | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 11.6B |
| IPO Year | N/A | N/A |
| Metric | SNN | FMS |
|---|---|---|
| Price | $30.09 | $23.60 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 2 | 2 |
| Target Price | ★ $36.25 | $30.00 |
| AVG Volume (30 Days) | ★ 1.1M | 617.5K |
| Earning Date | 03-16-2026 | 05-05-2026 |
| Dividend Yield | 2.48% | ★ 2.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.58 | N/A |
| Revenue Next Year | $5.60 | $3.83 |
| P/E Ratio | $64.97 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.08 | $20.02 |
| 52 Week High | $38.79 | $28.87 |
| Indicator | SNN | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 44.71 | 64.22 |
| Support Level | $29.10 | $23.50 |
| Resistance Level | $31.28 | $23.89 |
| Average True Range (ATR) | 0.49 | 0.33 |
| MACD | 0.03 | 0.25 |
| Stochastic Oscillator | 42.11 | 89.54 |
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.